Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 21, 2018Virtual Press Office and PR Newswire: General Trade show news
World Blockchain Summit is a global assemblage that takes place in 15+ destinations across the world. The summit unifies global blockchain experts and technology players in the blockchain sphere,...
-
Oct 21, 2018Virtual Press Office and PR Newswire: General Trade show news
Leap Therapeutics, Inc. (NASDAQ: LPTX) today presented clinical data from its ongoing Phase I/II study of DKN-01 in combination with Keytruda® (pembrolizumab) in patients with advanced...
-
Oct 21, 2018Virtual Press Office and PR Newswire: General Trade show news
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that updated phase 1 safety and efficacy data for [fam-] trastuzumab deruxtecan, an investigational HER2 targeting antibody...
-
Oct 21, 2018Virtual Press Office and PR Newswire: General Trade show news
Gcobisa Madlolo, an activist, a writer, a proud mother of twins and a fresh, inspiring and powerful voice for young women in her native South Africa and beyond is the recipient of the fifth...
-
Oct 21, 2018Virtual Press Office and PR Newswire: General Trade show news
The inaugural Global Zen Consciousness Conference (GZC) documentary production organized by Shaolin Chan Foundation (SCF) and produced by Shaolin Institute (IS) and DeRu Media (DRM) was held in...
-
Oct 21, 2018Virtual Press Office and PR Newswire: General Trade show news
Bayer and Loxo Oncology, Inc. (Nasdaq: LOXO), today announced updated clinical data for larotrectinib in adult and pediatric patients with TRK fusion cancer across 24 unique tumor types. The...
-
Oct 21, 2018Virtual Press Office and PR Newswire: General Trade show news
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, today announced the completed stage 1 safety and efficacy data from the ongoing Phase 1b clinical trial of...
-
Oct 21, 2018Virtual Press Office and PR Newswire: General Trade show news
Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan) and Servier jointly announced today the clinical data from the pivotal Phase III (TAGS) trial evaluating...
-
Oct 20, 2018Virtual Press Office and PR Newswire: General Trade show news
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies, cancer vaccines, and adoptive cell therapies2, presented updated clinical data on its lead...
-
Oct 19, 2018Virtual Press Office and PR Newswire: General Trade show news
The 26th China (Shenzhen) International Gift and Home Product Fair opens today at the Shenzhen Convention & Exhibition Center. The four-day fair (20-23 Oct), organized by Reed Huabo Exhibitions,...